Emris Pharma Israeli Company
EMRIS Pharma is developing a novel small molecule topically administrated for the prevention of skin toxicities induced by EGFR inhibitors (EGFRi). This innovative therapy intends to improve cancer patients’ quality of life and compliance with cancer therapy.
Health Tech & Life Sciences
Health Care
Medical
Pharmaceutical
Wellness
Alternatives
No alternatives listed yet.
Suggest an Alternative
Parent Companies/Investors
Office Locations
Nazareth, Israel
References
[1]
finder.startupnationcentral.org
- https://finder.startupnationcentral.org/company_page/emris-pharma
[2]
crunchbase.com
- https://www.crunchbase.com/organization/emris-pharma
External links are provided for reference and verification purposes.